
HLB Therapeutics Co.,Ltd. — Investor Relations & Filings
HLB Therapeutics Co., Ltd. is a biopharmaceutical company specializing in the development of innovative, first-in-class drugs for rare and intractable diseases. The company's clinical-stage pipeline focuses on addressing unmet medical needs in ophthalmology and oncology. Key development programs include RGN-259, a therapeutic agent for Dry Eye Disease and Neurotrophic Keratopathy, and OKN-007 for the treatment of Glioblastoma Multiforme. Additionally, the company is advancing a Natural Killer (NK) cell therapy through late-stage clinical trials to provide new therapeutic options for patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 주식등의대량보유상황보고서(일반) | 2026-06-02 | Korean | |
| 분기보고서 (2026.03) | 2026-05-15 | Korean | |
| 주식등의대량보유상황보고서(일반) | 2026-04-21 | Korean | |
| 전환사채(해외전환사채포함)발행후만기전사채취득 | 2026-04-01 | Korean | |
| 정기주주총회결과 | 2026-03-27 | Korean | |
| 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2026-03-27 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47927812 | 주식등의대량보유상황보고서(일반) | 2026-06-02 | Korean | ||
| 46354519 | 분기보고서 (2026.03) | 2026-05-15 | Korean | ||
| 34698114 | 주식등의대량보유상황보고서(일반) | 2026-04-21 | Korean | ||
| 33134768 | 전환사채(해외전환사채포함)발행후만기전사채취득 | 2026-04-01 | Korean | ||
| 33058879 | 정기주주총회결과 | 2026-03-27 | Korean | ||
| 33058873 | 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2026-03-27 | Korean | ||
| 33058854 | 본점소재지변경 | 2026-03-27 | Korean | ||
| 33038158 | 기업설명회(IR)개최 | 2026-03-25 | Korean | ||
| 33038143 | 기업설명회(IR)개최 | 2026-03-25 | Korean | ||
| 32985405 | 감사보고서제출 | 2026-03-19 | Korean | ||
| 32985399 | 사업보고서 (2025.12) | 2026-03-19 | Korean | ||
| 32983212 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-03-19 | Korean | ||
| 32969462 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-03-18 | Korean | ||
| 32960361 | 주식등의대량보유상황보고서(일반) | 2026-03-17 | Korean | ||
| 32928701 | 권리락 (무상증자) | 2026-03-11 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BIFIDO. Co. Ltd
Biotechnology firm developing human-derived Bifidobacterium…
|
238200 | KR | Manufacturing |
|
Binex Co., Ltd.
Biopharmaceutical firm with pharma manufacturing and biolog…
|
053030 | KR | Manufacturing |
|
BioAge Labs, Inc.
A clinical-stage biotech developing therapies for metabolic…
|
BIOA | US | Manufacturing |
|
Bioasis Technologies Inc.
Developing the xB3 platform to deliver therapeutics across …
|
BIOAF | CA | Manufacturing |
|
BioAtla, Inc.
Develops antibody-based therapeutics activated within the t…
|
BCAB | US | Manufacturing |
|
BIOBIJOU Co., Ltd.
Develops and manufactures medical aesthetic products like H…
|
489460 | KR | Manufacturing |
|
BioCardia, Inc.
Develops cell-derived therapeutics for cardiovascular and p…
|
BCDA | US | Manufacturing |
|
Biocartis Group NV
Develops and commercializes an automated molecular diagnost…
|
BCART | BE | Manufacturing |
|
Bioceltix S.A.
Develops stem cell-based medicinal products for veterinary …
|
BCX | PL | Manufacturing |
|
BioChem Pharma Inc.
Produces and commercializes high-quality pharmaceuticals, f…
|
— | CA | Manufacturing |
HLB Therapeutics Co.,Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/15813/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=15813 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=15813 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=15813 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 15813}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for HLB Therapeutics Co.,Ltd. (id: 15813)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.